Eisai President Says Japan, China to Become Key Battlefields for Aricept

Haruo Naito, President and CEO of Eisai, Explained the Future Strategy for Aricept Haruo Naito, president and CEO, Eisai, said at an announcement of company results on November 1 that for Eisai’s mainstay Alzheimer’s disease(AD) treatment Aricept (donepezil), which is...read more